Ultragenyx (RARE) Jumped 7.5% on FDA Approval. Can a $2.7 Million Gene Therapy Become a Commercial Success?

Yahoo Finance•Tue, Aug 25, 2026, 03:50 PM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Yahoo Finance](https://finance.yahoo.com/healthcare/articles/ultragenyx-rare-jumped-7-5-155003574.html)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Yahoo Finance ↗

#health #ultragenyx #rare #jumped #fda #approval #million #gene #therapy

More Headlines

EntertainmentRolling Stone• 12m ago

Dolly Parton’s Positivity Never Wavered When Addressing Health Issues Before Her Death

With her irrepressible sense of humor, Parton kept fans up to date as she battled immune and digestive system issues in recent months

TechnologyHacker News• 35m ago

FDA authorizes first wearable device that monitors ketone and blood sugar levels

22 points, 2 comments on Hacker News

AI & MLTechCrunch• 38m ago

Stability AI, maker of image generator Stable Diffusion, raises $76 million in fresh funding

The company's new fundraising total now stands at $232 million.

TechnologyHacker News• 39m ago

Youths on proposed social media ban: Some approval, questions around enforcement

3 points, 0 comments on Hacker News

EntertainmentTMZ• 41m ago

Doctors Linked To Jeffrey Epstein Being Investigated By New York Department of Health

The New York State Department of Health says it is taking a closer look at allegations involving doctors connected to Jeffrey Epstein, telling us the claims raised in recent media reports are "deeply troubling" and warrant review.

EntertainmentVariety• 42m ago

‘Outer Banks’ Season 5 Debuts With 9.4 Million Views in Four Days

“Outer Banks” returned to Netflix with its fifth and final season on Aug. 20 and reached 9. 4 million views in four days.